NCT06609330 · RECRUITING

Treatment of Chronic Anger and Aggression Following Military-Related Betrayal

This trial tests a talk-based program called CART, built for anger and aggression that grew out of a military betrayal. Researchers want to know if people stick with it, if it fits in a military outpatient clinic, and if it eases anger. It is 14 sessions, twice a week. Phase not applicable: this is an early look at practicality, not proof it works.

You may qualify if

  • Adult active duty military service members and veterans aged 18 or older.
  • Endorses a history of military-related betrayal (on the Modified Moral Injury Questionnaire)
  • Endorses problematic anger in the past month (as evidenced by a score of 12 or above on the Dimensions of Anger Reactions; DAR-5)
  • Engaged in at least 1 self-reported act of aggression in the past 1 month (on the Overt Aggression Scale-Modified; OAS-M)

You're excluded if

  • Participated in an anger management or trauma-focused intervention within the past 3 months as assessed by self-report.
  • Acute suicidality requiring immediate intervention, such as hospitalization as assessed by the Depressive Symptoms Index-Suicidality Subscale (DSI-SS) combined with follow up clinical interview for elevated scores.
  • Is currently homicidal with plans and intent to hurt a specific person and requiring immediate intervention as measured by self-report and follow-up with clinician if screened positive.
  • Moderate to severe brain injury as measured by inability to comprehend the informed consent document or baseline assessments.
  • Has severe alcohol consumption patterns as evidenced by a score of 19 or above on the Alcohol Use Disorders Identification Test (AUDIT).
  • Experiencing active psychosis or mania as measured by the Prodromal Questionnaire-Brief Version and the Mood Disorders Questionnaire.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-04-01

View full record on ClinicalTrials.gov

All APOE4 clinical trials